Skip to main content

LIVE

PLSE

Pulse Biosciences, Inc.

PLSE

NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $3.7B

$53.24

-2.69%

P/E

-45.50

Mkt Cap

$3.7B

52-Wk Range

$12.56–$55.37

52-Week Range

$12.56 - $55.37

P/E

-45.50

Fwd P/E

-43.97

Beta

1.63

Div Yield

0.00%

Avg Vol

400.8K

Shares Out

68.0M

Mkt Cap

$3.7B

Price action

Price chart

Up 254.0% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Proprietary Nano-Pulse Stimulation technology with strong patent protection
  • Tunable, software-enabled platform enabling multiple clinical applications
  • Non-thermal cellular ablation preserving adjacent tissue integrity
  • First-mover advantage in bioelectric medicine device category

Bear Case

1 risk

  • Above-average volatility (beta 1.6).

Growth

Stable outlook

Expanding clinical applications and regulatory approvals across multiple therapeutic areas

Value

Deep value opportunity - significant discount to Medical Devices peers

Momentum

Hot

+114.3% over 3m

Quality

Loss-making

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 4, 2026

Q3 26 RECAP

AUG 6, 2026

Reported EPS of -$0.36 vs -$0.29 consensus (-22.7% surprise). Revenue of $434.0K vs $533.3K expected (-18.6%).

EPS miss
Revenue miss

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-22.7%

Revenue trend · last 8Q

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$0

$0

$0

$0

$86.0K

$264.0K

$401.0K

-$401.0K

Margins · last 8Q

Gross

Profit

Wall Street consensus

2 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

2

100%

Hold

0%

Sell

0%

Median Price Target

Latest: Needham · Aug 17, 2026

vs Industry

How PLSE stacks vs Medical - Instruments & Supplies

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.